ACHI Stock UPDATES Accretive Health (ACHI) 7.3700 10/23/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Accretive Health (ACHI) 7.3700 $ACHI

Accretive Health Reports Inducement Grant
Business Wire - Wed Aug 13, 7:00AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that pursuant to the offer letter agreement entered into with Peter Csapo on August 6, 2014, the company granted to Csapo on August 12, 2014 a nonstatutory stock option and shares of restricted common stock (collectively the "Inducement Grants" as an inducement material to Csapo's acceptance of employment with the company. The Inducement Grants were approved by the company's Board of Directors on August 6, 2014. The company previously announced that Csapo has been appointed Chief Financial Officer and Treasurer of the company, effective August 12, 2014.

Blue Cross Blue Shield of Arizona Advantage Adds Executive Leadership
PR Newswire - Mon Aug 11, 4:55PM CDT
Blue Cross® Blue Shield® of Arizona Advantage (BCBSAZ Advantage), an affiliate of Blue Cross Blue Shield of Arizona (BCBSAZ), has named Dave Firdaus as Chief Executive Officer. BCBSAZ Advantage is a joint venture between Banner Health and BCBSAZ to sell Medicare products. Firdaus previously served as Senior Vice President of Population Health for Accretive Health, Inc.

Accretive Health Names Peter Csapo as CFO and Treasurer
Business Wire - Thu Aug 07, 7:01AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed Peter Csapo, CPA, former chief financial officer and area senior vice president for VHA, Inc., as senior vice president, chief financial officer and treasurer, effective Tuesday, August 12.

OTC Stocks Latest Trading News: Bioadaptives, Inc. Sigma Labs, Inc. Vape Holdings, Inc. Accretive Health, Inc. Osage Exploration and Development, Inc.
PR Newswire Europe - Tue Jul 15, 7:03AM CDT
LONDON, July 15, 2014 /PRNewswire/ --

Accretive Health Names Emad Rizk, M.D. as President and CEO
Business Wire - Thu Jul 10, 7:00AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that its Board of Directors has appointed Emad Rizk, M.D., president of McKesson Health Solutions, as Chief Executive Officer, President, and a member of the Board of Directors, effective July 21, 2014.

Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts
M2 - Tue Apr 01, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hnnrlm/healthcare_bpo) has announced the addition of the "Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts" report to their offering. The global healthcare BPO market is dominated by the U.S. A very large percentage of the healthcare BPO requirement arises out of the U.S. Europe is quickly emerging as another important source segment in this market. The U.S. and India are the two largest destination geographies. Philippines and Eastern Europe are two of the fastest growing destination segments in this market. The payer market is segmented into claims processing, member services, HR services, and finance and accounts segments. Claims processing is an important service segment in the payer outsourcing market. It is further sub-divided into claims indexing, claims investigation, claims adjudication, claims repricing, claims settlement, litigation management, and information management. The provider market is segmented into medical billing, medical coding, medical transcription, and finance and account segments. The pharmaceutical outsourcing market is segmented into contract research organizations (CRO), contract manufacturing organizations (CMO), and business support services. Each service segment in the pharmaceutical outsourcing market is divided into further sub-segments. The CRO service segment is sub-divided into drug discovery, pre-clinical, clinical phases I, II, III and IV, clinical data management and biostatistics, medical writing, regulatory services, and non-clinical functions. The CMO service segment is sub-divided into API manufacturing, and formulation and packaging. The non-clinical service segment is sub-divided into supply chain management and logistics, sales and marketing, and non-clinical functions. The report also highlights the marketing KPO function in the sales and marketing outsourcing segment. Scope Healthcare BPO Market Payer - Claims Processing - HR Services - Finance & Accounts Provider - Medical Billing & Coding Pharmaceutical - Clinical Trial - Contract Manufacturing - Non-Clinical Services Key Topics Covered: - Introduction - Executive Summary - Market Overview - Healthcare Payer Outsourcing Market - Healthcare Provider Outsourcing Market - Pharmaceutical Outsourcing Market - Geographical Analysis - Competitive Landscape - Company Profiles - Accenture Plc - Accretive Health, Inc. - Anthelio Healthcare Solutions, Inc. - Boehringer Ingelheim Gmbh - Catalent Pharma Solutions, Inc. - Charles River Laboratories International, Inc. - Cognizant Technology Solutions Corporation - Covance, Inc. - Gebbs Healthcare Solutions, Inc. - Genpact Limited - Ibm Corporation - Icon Plc - Igate Patni - Infosys Bpo Limited - Inventiv Health Inc - Lonza Group Ltd. - Medusind Solutions Inc - Mphasis Limited - Omega Healthcare Management Services Pvt Ltd - Parexel International Corporation - Patheon Inc - Pharmaceutical Product Development, Inc. - Piramal Enterprises Limited - Quintiles Transnational Holdings, Inc. - Tata Consultancy Services Ltd - Tech Mahindra - Teleradiology Solutions Pvt Ltd. - Wns (Holdings) Limited - Xerox Corporation Visit http://www.researchandmarkets.com/research/hn...thcare_bpo
XRX: 12.78 (+0.57), CRL: 62.56 (+0.73), CTSH: 44.52 (+0.38), CVD: 80.42 (+1.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 188

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 169

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharma Equity Group's Journey Through H1 2025 Financials

Updated Category News Views 138

Pharma Equity Group's Interim Report for First Half of 2025 Key Highlights of H1 2025 Recently, Pharma Equity Group A/S underwent a thorough review by its Board of Directors and Executive Board, affirming their progress and strategies during the first half of 2025. Strategic Developments In a significant strategic shift, Pharma Equity Group has launched a new growth...

Continue Reading
Euro Manganese Welcomes New Director to Enhance Leadership Team

Updated Category News Views 110

Euro Manganese Inc. took a bold step back in 2024 when it brought on board Ms. Ludivine Wouters as a non-executive Director. This move was no ordinary appointment; it marked a significant shift in the company’s strategy as it aimed to solidify its presence in the battery materials sector, especially crucial for the electric vehicle (EV) industry. Strategic Shift: New...

Continue Reading
Gneuton Innovations: Revolutionizing Water Sustainability in AI

Updated Category News Views 333

Gneuton Innovations in AI Data Centers Gneuton, a groundbreaking clean technology company, is making waves in the field of regenerative AI infrastructure. The company has recently introduced a unique deployable water purification system that operates within gas turbine-powered AI data centers. This innovative system utilizes a patented thermal distillation technique,...

Continue Reading
Transamerica Reinforces Leadership for Retirement Expansion

Updated Category News Views 10

Transamerica's Next Phase: Leadership Moves in Retirement Transamerica just pulled a move that’s both bold and calculated. They’ve beefed up their retirement distribution squad with Danny Kling and Kevin Murphy stepping into the spotlight. These guys are bringing heaps of experience and a fresh jolt of energy to keep the momentum going. No doubt this is Transamerica...

Continue Reading
Unity Bancorp Drives Forward with Exciting Dividend Announcement

Updated Category News Views 129

Unity Bancorp Declares Cash Dividend for Shareholders Unity Bancorp, Inc. (NASDAQ: UNTY), the parent company of Unity Bank, has made an exciting announcement regarding its commitment to rewarding shareholders. The company's Board of Directors has declared a cash dividend amounting to $0.15 per common share. This dividend, representing a positive sign for shareholders,...

Continue Reading